{"slideshow_credits": null, "snippet": "Rottapharm dropped plans for an offering, saying unfavorable market conditions led to \u201ca rapid change in the expectations of investors on European assets and, in particular, on Southern European assets.\u201d", "abstract": "Rottapharm dropped plans for an offering, saying unfavorable market conditions led to \u201ca rapid change in the expectations of investors on European assets and, in particular, on Southern European assets.\u201d", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Chad", "role": "reported", "lastname": "BRAY", "rank": 1, "organization": ""}], "original": "By CHAD BRAY"}, "web_url": "http://dealbook.nytimes.com/2014/07/10/italian-drug-maker-rottapharm-pulls-planned-i-p-o/", "lead_paragraph": null, "headline": {"main": "Italian Drug Maker Rottapharm Pulls Planned I.P.O.", "kicker": "DealBook"}, "_id": "53be8a4338f0d81c938698e3", "word_count": "220", "multimedia": [], "pub_date": "2014-07-10T08:41:12Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "glocations", "value": "Europe", "rank": "1"}, {"name": "organizations", "value": "Rottapharm SpA", "rank": "1"}, {"name": "subject", "value": "Stocks and Bonds", "rank": "3"}, {"name": "subject", "value": "Initial Public Offerings", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}